Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ursula Barnas"'
Severe nephrotic syndrome and early end-stage diabetic kidney disease in ABCC8-MODY12: A case report
Autor:
Sophie H. Schmidt, Ursula Barnas, Christof Aigner, Peter Wolf, Nicolas Kozakowski, Renate Kain, Thomas Scherer, Alice Schmidt, Gere Sunder-Plassmann
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
A 24-year-old man with diabetes mellitus presented with advanced kidney disease and severe proteinuria. Genetic testing revealed ABCC8-MODY12 (OMIM 600509), and a kidney biopsy showed nodular glomerulosclerosis. He commenced dialysis shortly thereaft
Externí odkaz:
https://doaj.org/article/66aff9dec0f44f7280c1bd2e5ac76122
Autor:
Alexander R. Rosenkranz, Ursula Barnas, Margit Hemetsberger, Clemens Wieser, Christine Jaeger, Daniel Dekic, Ulrich Neyer, Wolfgang Pronai
Publikováno v:
Wiener Medizinische Wochenschrift. 164:109-119
ALTERNATE is an international observational study evaluating biweekly darbepoetin alfa (DA) in adult dialysis patients in clinical practice. Austrian ALTERNATE results are presented here (n = 505). The follow-up study ALTERNATE follow-up (AFU) follow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b05887e07cb516c8854017009b33f2e
https://doi.org/10.1007/s10354-013-0256-7
https://doi.org/10.1007/s10354-013-0256-7
Autor:
Martin Auinger, Gere Sunder-Plassmann, Manuela Födinger, Ursula Barnas, Josef Kletzmayr, Brigitte Enzenberger, Walter H. Hörl, Wolfgang C. Winkelmayer, Heidi Buchmayer, Oskar Janata, Gernot Paul, Menelaos Papagiannopoulos, Jadwiga Wojcik
Publikováno v:
Scopus-Elsevier
Homocysteine is associated with atherosclerosis and enhanced cardiovascular risk. In previous studies, treatment with folic acid up to 15 mg/d failed to correct hyperhomocysteinemia in the majority of end-stage renal disease patients. A dose of 30 or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82e4f180f6c4f5b513fe64273194bc19
https://doi.org/10.1681/asn.v1161106
https://doi.org/10.1681/asn.v1161106
Publikováno v:
The New England journal of medicine. 322(24)
Anemia is a common complication of multiple myeloma. It resolves early in the disease if chemotherapy induces a complete remission, but persists if the disease progresses, causing disabling symptoms and often requiring blood transfusions. We treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92fcd8ee60b88726c0c7795ecdf54dd2
https://pubmed.ncbi.nlm.nih.gov/1984168
https://pubmed.ncbi.nlm.nih.gov/1984168